121 related articles for article (PubMed ID: 3444181)
1. [A retrospective clinical study of relapsed prostatic cancer].
Takigawa H; Kagawa S; Aga Y; Kurokawa K
Nihon Hinyokika Gakkai Zasshi; 1987 Sep; 78(9):1545-52. PubMed ID: 3444181
[No Abstract] [Full Text] [Related]
2. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
Gleason DF; Mellinger GT
J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
[No Abstract] [Full Text] [Related]
3. Prognosis of prostatic carcinoma.
Mellinger GT
Recent Results Cancer Res; 1977; (60):61-72. PubMed ID: 866797
[No Abstract] [Full Text] [Related]
4. [Personal reflections on cancer of the prostate].
Wojewski A
J Urol Nephrol (Paris); 1968 Jun; 74(6):451-60. PubMed ID: 4300445
[No Abstract] [Full Text] [Related]
5. Prognosis of prostatic cancer.
Arvola I; Lilius HG; Uusi-Penttilä S
Ann Chir Gynaecol Fenn; 1972; 61(1):25-9. PubMed ID: 5021539
[No Abstract] [Full Text] [Related]
6. [The role of PSA in prostatic adenocarcinoma].
Manca GP
Minerva Med; 1990 Apr; 81(4):261-4. PubMed ID: 1692981
[TBL] [Abstract][Full Text] [Related]
7. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
Blackard CE; Byar DP; Jordan WP
Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
[No Abstract] [Full Text] [Related]
8. Radioimmunoassay for prostatic acid phosphatase in early prostatic carcinoma.
Samuell CT; Morgans BT; O'Donoghue EP
Br J Urol; 1984 Apr; 56(2):208-12. PubMed ID: 6498440
[TBL] [Abstract][Full Text] [Related]
9. The appropriate uses of prostatic acid phosphatase determination in the diagnosis of adenocarcinoma of the prostate.
Griffiths J
Ann N Y Acad Sci; 1982; 390():100-3. PubMed ID: 6953922
[No Abstract] [Full Text] [Related]
10. Considerations for the use of testosterone with systemic chemotherapy in prostatic cancer.
Fowler JE; Whitmore WF
Cancer; 1982 Apr; 49(7):1373-7. PubMed ID: 7059952
[TBL] [Abstract][Full Text] [Related]
11. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
Bruce AW; Mahan DE
Ann N Y Acad Sci; 1982; 390():110-21. PubMed ID: 6953923
[No Abstract] [Full Text] [Related]
12. Prostatic acid phosphatase: its current clinical status.
Heller JE
J Urol; 1987 Jun; 137(6):1091-103. PubMed ID: 3295298
[No Abstract] [Full Text] [Related]
13. Cystic recurrence of prostate cancer.
Radolinski B; Diner EK; Kwart AM
Urology; 2006 Apr; 67(4):844. PubMed ID: 16600351
[No Abstract] [Full Text] [Related]
14. Acid phosphatase and prostatic carcinoma.
Clin Chem; 1978 Jan; 24(1):129-34. PubMed ID: 201393
[No Abstract] [Full Text] [Related]
15. Benign positive margins after radical prostatectomy means a poor prognosis--pro.
Djavan B; Milani S; Fong YK
Urology; 2005 Feb; 65(2):218-20. PubMed ID: 15708025
[No Abstract] [Full Text] [Related]
16. Definitive radiation therapy of carcinoma of the prostate. A report on 15 years of experience.
Ray GR; Cassady JR; Bagshaw MA
Radiology; 1973 Feb; 106(2):407-18. PubMed ID: 4630765
[No Abstract] [Full Text] [Related]
17. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
[TBL] [Abstract][Full Text] [Related]
18. Screening for adenocarcinoma of the prostate.
Miles BJ
Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
[No Abstract] [Full Text] [Related]
19. [New prospective diagnostic serum markers in prostatic cancer].
Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
[No Abstract] [Full Text] [Related]
20. [Observations on the prognosis of conservatively treated prostatic neoplasm].
Hasselbacher K; Heinrichs H
Z Urol Nephrol; 1974 Mar; 67(3):161-4. PubMed ID: 4849272
[No Abstract] [Full Text] [Related]
[Next] [New Search]
